Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
Description
We selected fifty one drugs already known for their potential disease treatment roles in various studies and subjected to docking and molecular docking simulation (MDS) analyses. Five of them showed promising features that are discussed and suggested
